سيمبادول
Simbadol (buprenorphine injection) is a high-concentration partial mu-opioid agonist indicated for the control of postoperative pain associated with surgical procedures in cats, providing 24-hour continuous analgesia per dose.
Dosage Form
Injection
Product Type
Pharmaceutical
Manufacturer
Package
10 mL multi-dose amber glass vial containing 1.8 mg/mL buprenorphine
| Species | Dosage | Route | Duration |
|---|---|---|---|
| Cat | 0.24 mg/kg (0.13 mL/kg) body weight | Subcutaneous (SC) | Once daily (every 24 hours) for up to 3 days |
No withdrawal information available.
Control of postoperative pain associated with surgical procedures (such as ovariohysterectomy, castration, and soft tissue procedures) in cats.
Do not use in cats with known hypersensitivity to buprenorphine.
Do not use in cats with severe respiratory depression or traumatic brain injury.
Opioids may produce respiratory depression, sedation, and mild hypothermia.
Use with caution in debilitated cats or those with hepatic, renal, or pulmonary impairment.
Safety has not been evaluated in cats younger than 4 months of age or in breeding, pregnant, or lactating cats.
Sedation, dysphoria, mydriasis, decreased appetite, hypothermia, or mild transient bradycardia.
Simbadol Prescribing Information
LeafletNo diseases linked.
No data available
Information has not been added yet.
No data available
Information has not been added yet.
Manufacturer
No alternatives available.